Today, we would like to share the talk that Steven A. Garan gave at our recent conference in New York, Ending Age-Related Diseases: Investment Prospects & Advances in Research. The conference focused on bringing together the world of research and investment and bringing thought leaders, investors, the media, and the general public together.
Steven A. Garan is the Director of Bioinformatics at the Center for Research and Education on Aging (CREA) and a researcher at UC Berkeley National Laboratory. In his talk at Ending Age-Related Diseases, he discussed the impact of various present and future Silicon Valley technology breakthroughs on overcoming aging.
He gave a somewhat future-facing talk at the conference, which may surprise some people given his senior position at Berkeley; however, we consider this a sign of how times have changed in the last decade. Ten years ago, talking about ending aging would potentially have damaged your career and gotten you unfairly labeled as fringe, much as Dr. Aubrey de Grey was for many years until many others joined his crusade to end aging. It was therefore refreshing to hear Steven talk so positively about the future of biomedical science and about doing something about aging itself in order to end age-related diseases.
Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences.
His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine.
Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals.
Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
As rejuvenation biotechnology begins to take root, more and more biotech companies are joining the fight against aging. Here’s what’s happened in research, development, investment, and advocacy last month. LEAF News Our fifth annual conference, […]
A study published in Obesity suggests that metformin may decrease the gains in cardiorespiratory performance brought on by exercise. The world’s most common diabetes drug Metabolic syndrome, which is […]
“Transhumanism is a philosophy, worldview, and a movement,” Dr. Natasha Vita-More states in the book “Transhumanism: What is it?” Essentially, it’s the idea of being able to move beyond being human, and finding solutions to living longer, healthier […]
June 2022 marked the first anniversary of VitaDAO passing its Gnosis Token Auction. Since its founding, the biotech DAO has invested over $2.5 million […]
A large-scale, randomized, controlled trial has found that in aging adults, cocoa extract does not affect the prevalence of adverse cardiovascular events but decreases their lethality […]
This episode on Lifespan News is on a new study detailing how Vitamin B and omega-3 fatty acids work together to improve brain health. Script Researchers […]
Write a comment: